Cardiovascular Systems to Webcast Fiscal 2017 First-Quarter Earnings Conference Call Wednesday, October 26
October 05 2016 - 4:05PM
Business Wire
Live Webcast at 3:45 p.m. CT (4:45 p.m.
ET)
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a
live webcast of its fiscal 2017 first-quarter conference call on
Wednesday, October 26, 2016, at 3:45 p.m. CT (4:45 p.m. ET). Scott
Ward, Chairman, President and Chief Executive Officer, and Larry
Betterley, Chief Financial Officer, will discuss the company’s
results for its fiscal first quarter ended September 30, 2016, and
its financial outlook. The company will issue a post-market
earnings release prior to the call on October 26.
To access the live webcast, go to the events section of the
company’s investor relations website,
http://investors.csi360.com/Investors/Events, on the day of the
conference call and click on the webcast link. A webcast replay
will be available beginning at 6:45 p.m. CT the same day.
To participate in the conference call, dial (877) 201-0168 and
enter 93470708. Please dial in at least 10 minutes prior to the
call.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (855) 859-2056 and
enter 93470708. The audio replay will be available beginning at
6:45 p.m. CT on Wednesday, October 26, 2016, through 10:59 p.m. CT
on Wednesday, November 2, 2016.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted 510(k) clearance for the use of the Orbital
Atherectomy System in peripheral arteries in August 2007. In
October 2013, the company received FDA approval for the use of the
Orbital Atherectomy System in coronary arteries. To date, over
260,000 of CSI’s devices have been sold to leading institutions
across the United States. For more information, visit the company’s
website at www.csi360.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161005006254/en/
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan,
612-455-1709matt.sullivan@padillacrt.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Sep 2023 to Sep 2024